Claudio Isella Selected Research

Claudio Isella Research Topics

Disease

26	Neoplasms (Cancer) 01/2023 - 05/2008
16	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 05/2011
6	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2018
5	Neoplasm Metastasis (Metastasis) 10/2022 - 05/2011
3	Stomach Neoplasms (Stomach Cancer) 11/2019 - 01/2015
2	Melanoma (Melanoma, Malignant) 01/2023 - 01/2018
2	Rectal Neoplasms (Rectal Cancer) 01/2018 - 04/2015
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 02/2012
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2022
1	Carcinogenesis 01/2022
1	Intestinal Neoplasms (Intestinal Cancer) 01/2022
1	Adenoma (Adenomas) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Pulmonary Hypertension 12/2021
1	Vascular Diseases (Vascular Disease) 12/2021
1	Hydrocephalus (Hydrocephaly) 12/2021
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2021
1	Aneurysm (Aneurysms) 12/2021
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 12/2021
1	Glioblastoma (Glioblastoma Multiforme) 10/2020
1	Osteosarcoma (Osteogenic Sarcoma) 06/2020
1	Pseudomyxoma Peritonei 06/2020
1	Appendiceal Neoplasms (Appendix Cancer) 06/2020
1	Residual Neoplasm 01/2020
1	Disease Progression 01/2020
1	Carcinoma (Carcinomatosis) 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2017
1	Microsatellite Instability 01/2017
1	Inflammation (Inflammations) 02/2015
1	Fibrosarcoma 09/2009

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2015
5	Phosphotransferases (Kinase)IBA 06/2020 - 01/2015
4	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2018
4	LigandsIBA 01/2020 - 05/2011
3	tyrosine receptor (receptor, tyrosine)IBA 06/2020 - 01/2015
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2011
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2013 - 05/2011
2	olaparibIBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
2	trametinibIBA 12/2021 - 06/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 01/2018
2	pevonedistatIBA 07/2021 - 01/2017
2	AntibodiesIBA 01/2020 - 11/2011
2	Cetuximab (Erbitux)FDA Link 01/2018 - 11/2011
2	MicroRNAs (MicroRNA)IBA 01/2016 - 11/2015
2	Messenger RNA (mRNA)IBA 11/2015 - 06/2013
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022
1	CateninsIBA 09/2022
1	neuroligin 1IBA 09/2022
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2022
1	TrabectedinIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	regorafenibIBA 11/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 07/2021
1	Dexfenfluramine (Redux)IBA 10/2020
1	pazopanib FDA Link 06/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Semaphorins (Semaphorin)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2018
1	Amino Acids FDA Link 11/2018
1	PhosphoenolpyruvateIBA 11/2018
1	CarbonIBA 11/2018
1	Nucleic AcidsIBA 11/2018
1	Androgen Receptors (Androgen Receptor)IBA 07/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Neuropilin-1IBA 01/2018
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2015
1	CytokinesIBA 02/2015
1	raf KinasesIBA 01/2015
1	Proto-Oncogene Proteins c-metIBA 06/2013
1	OligonucleotidesIBA 06/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012
1	AntagomirsIBA 02/2012
1	Oncogene Proteins (Oncogene Protein)IBA 11/2011
1	MetalsIBA 09/2009
1	CopperIBA 09/2009
1	Cisplatin (Platino)FDA LinkGeneric 09/2009
1	Heavy MetalsIBA 09/2009

Therapy/Procedure

13	Therapeutics 01/2023 - 05/2008
2	Precision Medicine 11/2019 - 11/2011
1	Ventriculoperitoneal Shunt 12/2021
1	Cytoreduction Surgical Procedures 06/2020
1	Hyperthermic Intraperitoneal Chemotherapy 06/2020
1	Aftercare (After-Treatment) 01/2020
1	Lasers (Laser) 01/2018
1	Radiotherapy 04/2015